Key facts
- Fay’s last known valuation is $500.0M (Feb 2025).
- It has raised $75.0M; the latest was Early Stage VC ($50.0M) in Feb 2025.
- Notable investors include General Catalyst, Forerunner Ventures, Goldman Sachs Growth Equity, 1984 Ventures, Jake Cooper — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Fay
- ·The full record, as it builds
Funding rounds
No funding rounds for Fay are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Fay
Developer of a digital healthcare platform designed for medical nutrition therapy and insurance-integrated dietary counseling. The company's platform connects patients with a nationwide network of board-certified registered dietitians and managing automated insurance credentialing, telehealth scheduling, and HIPAA-compliant communication, enabling healthcare providers to achieve better chronic disease management and proactive wellness outcomes.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2021
- Employees
- 33
- Website
- faynutrition.com/
- Ownership
- Privately Held (backing)
Fay doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Fay shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Fay in its N-PORT filings yet. We sweep new filings monthly.